Madduri Ravin Rao

CIK 1792006 · Chief Medical Officer · last filed 2026-07-01

Madduri Ravin Rao is a Chief Medical Officer who has filed 4 SEC Form 4 insider transactions across 3 companies since 2019. The most recent filing, for AUTL, was dated Jul 1, 2026.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$0

Companies

3

Total Filings

4

Lifetime Open-Market Net

$0

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
AUTL	Director	—	$1.69	—	$0	1	2026-07-01
DBVT	Director	—	$16.18	—	$0	1	2021-06-11
Spyre Therapeutics, Inc. (AGLE) Delisted	Chief Medical Officer	—	$12.01	—	$0	2	2020-02-19

Recent Filings

4 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2026-07-01	AUTL	Grant (A)	—	$0	EDGAR
2021-06-11	DBVT	Buy (P)	—	$0	EDGAR
2020-02-19	Spyre Therapeutics, Inc. (AGLE) Delisted	Grant (A)	—	$0	EDGAR
2019-11-04	Spyre Therapeutics, Inc. (AGLE) Delisted	Grant (A)	—	$0	EDGAR

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.